ArticleThe Journal of pharmacology and experimental therapeutics2025
Impact of chemical flavorants on reinforcement-related behavior in an adolescent mouse model of vaping self-administration.
Article in The Journal of pharmacology and experimental therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Synthetic cooling agents enhance nicotine reinforcement and mesolimbic dopamine signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Article
- Effects of commercial unflavored and vanilla-flavored e-liquids on nicotine intake and withdrawal.bioRxiv : the preprint server for biology · 2026Article
- Impact of flavorants on nicotine vapor self-administration in adolescent mice: Cherry on top?The Journal of pharmacology and experimental therapeutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Electronic nicotine delivery systems (ENDSs) are a unique from combustible cigarettes due to the availability of flavor options which make these devices more attractive. Prior preclinical investigations have determined that menthol and green apple flavorants can enhance nicotine reward and reinforcement by altering dopamine transmission via nicotinic acetylcholine receptor modulation in reward-mediating brain areas. In this study, we investigated the impact of vanilla (vanillin and ethyl vanillin) and cherry (ethyl vanillin, vanillin, ethyl acetate, ethyl maltol, and maltol) flavors on reinforcement-related behavior with and without nicotine. Male and female adolescent C57BL/6J mice were used in an e-Vape self-administration assay. Four combinations were shown to increase reinforcement-related behavior: nicotine plus menthol, nicotine plus cherry, nicotine plus vanilla, and vanilla alone. We observed that zero-nicotine cherry-flavored ENDSs did not produce robust reinforcement-related behavior when compared with control vapor. We observed that zero-nicotine vanilla-flavored ENDSs did produce reinforcement-related behavior in adolescent male and female mice; the addition of nicotine did not produce a significant difference in active nose pokes or deliveries but did have increased active-to-inactive ratio. Additionally, we found that vanilla alone was able to modulate tonic and phasic release of dopamine in the nucleus accumbens core. We also looked at the physical interactions of green apple and vanilla flavors on nicotinic subunits. These data provide additional evidence that some chemical flavors promote vaping-related behaviors without the inclusion of nicotine. SIGNIFICANCE STATEMENT: The e-Vape self-administration paradigm is a translationally relevant method of investigating the impact of different flavorants on nicotine use. Because most electronic nicotine delivery system users vape flavored nicotine products, it raises questions about how chemical flavorants alter nicotine addiction and if they increase abuse liability themselves. In accordance with our prior findings on green apple, vanilla flavorants are able to cause changes in reward-related behaviors in the absence of nicotine potentially through altering dopamine release in the nucleus accumbens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.